Top compounds associated with response to SIGLECL1


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA DMOG GDSC1000 pan-cancer AAC -0.07 0.03
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.03
mRNA BMS-345541 GDSC1000 pan-cancer AAC -0.067 0.03
mRNA QL-XII-47 GDSC1000 pan-cancer AAC -0.07 0.03
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.03
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.063 0.03
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.069 0.03
Download CSV